Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX)

69 filings reported holding BCAX - Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Bicara Therapeutics Inc. - Common Stock, par value $0.0001 per share (BCAX) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 36,408,664 shares of 54,347,826 outstanding shares and own 67% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (6,955,993 shares), Siren, L.L.C. (3,072,827 shares), TPG GP A, LLC (3,010,425 shares), FMR LLC (2,273,792 shares), Omega Fund Management, LLC (2,204,650 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1,795,174 shares), BRAIDWELL LP (1,657,600 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,538,934 shares), Fairmount Funds Management LLC (1,284,169 shares), and JANUS HENDERSON GROUP PLC (1,188,191 shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.